Search clinical trials for: Angiotensin II Infusion

Total 12884 results

Assaf-Harofeh Medical Center

Unknown

Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)

Diabetes Mellitus | Atherosclerosis
Boehringer Ingelheim

Completed

Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers

Healthy
Università degli Studi dell'Insubria

Unknown

Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan

Diastolic Function | Left Atrial Volume | Renin Angiotensin System | Hypertensive Heart Disease | Antihypertensive Drugs

Italy
HK inno.N Corporation

Recruiting

A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers

Hypertension

Korea, Republic of
Anna Stanhewicz, PhD

Recruiting

Losartan for Improved Vascular Endothelial Function After Preeclampsia (LIVE-PE)

Preeclampsia Postpartum

United States
Teva takeda

Active, not recruiting

A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood Pressure

Hypertension

Japan
Daiichi Sankyo, Inc.

Completed

A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis

Atherosclerosis
Roxane Laboratories

Completed

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions

Hypertension

United States
University of South Florida
National Cancer Institute (NCI)

Withdrawn

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Lung Cancer | Dyspnea | Pulmonary Complications | Radiation Fibrosis
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI); Merck Sharp & Dohme LLC

Completed

Efficacy of Losartan in Preventing Progression of COPD

Smoking | Emphysema | COPD | Chronic Bronchitis

United States
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients

Hypertension

Romania
Bayer

Completed

COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland (COUGH)

Hypertension

Poland
Kumamoto University
Japan Heart Foundation; The 4C trial bureau

Completed

Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

Coronary Artery Disease | Hypertension

Japan
Medical University of Gdansk

Completed

The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria

Proteinuria | Chronic Kidney Disease
Baker Heart and Diabetes Institute

Unknown

The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension

Hypertension | Abdominal Obesity

Australia
Bayer
International Clinical Trials Association

Completed

Survey to Assess Why People Are Not Responding to Treatment in Hypertension

Arterial Hypertension

France
Daiichi Sankyo Co., Ltd.

Completed

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Type 2 Diabetes Mellitus | Diabetic Nephropathy | Proteinuria

Japan, China
Pfizer

Completed

Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide

Hypertension
Beth Israel Deaconess Medical Center

Terminated

Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery

Peripheral Vascular Disease | Abdominal Aortic Aneurysm

United States
Second Affiliated Hospital, School of Medicine,...

Recruiting

Azilsartan in Patients With Diabetic Kidney Disease and Hypertension

Diabetic Kidney Disease | Proteinuria | Blood Pressure | Kidney Dysfunction

China
Boehringer Ingelheim

Completed

A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

Hypertension | Diabetic Nephropathies

Taiwan, United States, Canada, Thailand, Korea, Republic of, Argentina, Australia, Brazil, Mexico, New Zealand
University of Oxford

Completed

The Effect of Losartan on Emotional Processing in Healthy Volunteers

Healthy Volunteers
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Pediatric Hypertension With or Without CKD

Belgium, Poland, Italy, Germany, Guatemala, France, Hungary, Brazil, Lithuania
Takeda

Completed

Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"

Hypertension
Sanofi

Completed

AVE7688 in Patients With Mild to Moderate Blood Pressure (RAVEL-1)

Hypertension

United States, Canada, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Turkey, Malaysia, Singapore, Taiwan, Mexico, Argentina, Korea, Republic of, Chile, Hong Kong, South Africa, Greece
Boehringer Ingelheim

Completed

Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis (ESPRIT)

Hypertension
Institute for Clinical and Experimental Medicine
Ministry of Health, Czech Republic

Completed

Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes

Insulin Resistance | Type 2 Diabetes

Czech Republic
Novartis

Completed

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus (ViVID)

Hypertension

United States
Bayer

Completed

COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in Slovakia (COUGH)

Hypertension

Slovakia
Daewoong Pharmaceutical Co. LTD.

Completed

A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276

Healthy Volunteers

Korea, Republic of
Novartis

Completed

Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal (ASSERTIVE)

Hypertension

Brazil, Canada, Ecuador, Germany, Hungary, Korea, Republic of, Malaysia, Mexico, Panama, Philippines, Singapore, Slovakia, Spain, Turkey, United Kingdom, Venezuela
National Taiwan University Hospital

Unknown

Olmesartan on Ambulatory Blood Pressure Change

Hypertension

Taiwan
AHEPA University Hospital

Completed

Diabetic Autonomic Neuropathy and Left Ventricular Function (DANEL)

Diabetes Mellitus

Greece
Hannover Medical School
DLR German Aerospace Center

Withdrawn

Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure (ARNI-Sy)

Heart Failure

Germany
Chinese PLA General Hospital

Unknown

Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease

Chronic Kidney Disease

China
Boehringer Ingelheim

Completed

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Cardiovascular Diseases

United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Italy, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand and more
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus

Macroalbuminuric Diabetic Nephropathy

Brazil
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

Albuminuria

United States, Spain, Netherlands, Canada, Italy, Mexico, Israel, Australia, Russian Federation, United Kingdom, France, Germany, Latvia, Lithuania
Michael Mauer, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Merck... and other collaborators

Completed

Renin Angiotensin System Study (RASS/B-RASS)

Type 1 Diabetes

Canada
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Withdrawn

Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

Hyperoxaluria
National Institute of Cardiovascular Diseases,...

Completed

Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction

Heart Failure, Systolic

Pakistan
Postgraduate Institute of Medical Education and...

Completed

Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy (START1DM)

Diabetic Nephropathy

India
University of Electronic Science and Technology...

Recruiting

The Effects of Losartan on Attention Control: An Eye-tracking Study

Healthy

China
University of Electronic Science and Technology...

Recruiting

Losartan Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study

Healthy

China
Tyler J Curiel

Not yet recruiting

Telmisartan in Prostate Cancer

Prostate Cancer

United States
Medical University of Gdansk
Jagiellonian University; Medical University of Silesia; Pomeranian Medical University... and other collaborators

Recruiting

Cardiorenal Effecs of Losartan in Kidney Transplant Recipients (CELART)

Renal Transplant Failure | Cardiovascular Complication

Poland
University of Kansas Medical Center

Recruiting

Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240

Cystic Fibrosis

United States
Organon and Co

Completed

ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)

High Blood Pressure
Radboud University Medical Center

Terminated

Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

Severe Acute Respiratory Syndrome | COVID-19 | COVID | Acute Respiratory Distress Syndrome | SARS-CoV-2

Netherlands

Search clinical trials for: Angiotensin II Infusion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations